The Agenda for Familial Hypercholesterolemia
Published: October 28, 2015
- The American Heart Association (AHA) provides an agenda to further familial hypercholesterolemia (FH) diagnosis and treatment practices, building on the platform provided by recent guidelines and reviews of progress in the field.
- Familial hypercholesterolemia is a highly prevalent, underdiagnosed and undertreated genetic disorder causing premature atherosclerotic coronary artery heart disease.
- Because FH can be asymptomatic and have potentially devastating consequences.
CS.05 Results of ODYSSEY
David Goff Jr., MD, PhD, and Amit Khera, MD discuss the science presented in CS.05 on the Results of ODYSSEY, which were presented at the American Heart Association Scientific Sessions 2014 in Chicago.
Supporting Materials
- Commentary: Familial Hypercholesterolemia: Our Call to Action by Nathan D. Wong, PhD, MPH, FAHA, FACC
- Top Things to Know: The Agenda for Familial Hypercholesterolemia